Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02393625
Title Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | ESP | CAN | BEL | AUS

Facility Status City State Zip Country Details
Mayo Clinic - Arizona Scottsdale Arizona 85259 United States Details
Massachusetts General Hospital Thoracic Oncolgoy Boston Massachusetts 02115 United States Details
Fox Chase Cancer Center StudyCoordinator Philadelphia Pennsylvania 19111 United States Details
Novartis Investigative Site Heidelberg Victoria 3084 Australia Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 1Z6 Canada Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field